“…For instance, individual studies from Africa reported Cz prevalence in PMF as 0.00% in PIF 117 , 5.36% 118 , and 11.25% 10 in Egypt; 0.00% 119 (India, PIF), 1.10% 120 (China, PIF), 1.45% 121 (Jordan, PIF), 1.67% 11 (China, PIF), 2.00% 7 (China, PIF), 3.08% 9 (Iraq, PIF), 3.13% 122 (Bangladesh, PIF), 4.07% 123 (China, PIF), 4.12% 124 (China, Ifoods), 4.34% 125 (China, PIF), 5.00% 126 (Iran, PIF), 6.04% 127 (Japan, PIF), 6.86% 127 (Korea, PIF), 7.20% 128 (Iran, PIF), 7.51% 129 (China, IFF), 8.00% 126 (Iran, Ifoods), 10.60% 130 (China, EPIF), 11.94% 40 (China, IFF), 12.28% 131 (China, PIF), 16.53% 11 (China, CPIF), 16.88% 132 (China, PIF), and 47.67% 133 (Korea, IFF) in Asia. In Europe, individuals studies demonstrated Cz prevalence in PMF as 0.00% 134 , Czech Republic, IFF/PIF; 0.00% 135 (Turkey, CPIF), 0.00% 136 (Ireland, PIF), 0.35% 107 (Netherlands, PIF), 0.50% 137 (Slovakia, PIF), 0.74% 138 (UK, FUF), 1.00% 139 (Germany, EPIF), 1.16% 137 (Slovakia, CPIF), 2.50% 136 (Ireland, IFF), 3.33% 140 (Czech Republic, PIF), 4.09% 141 (Austria, PIF), 10.00% 142 ( Turkey, PIF), 11.11% 140 (Czech Republic, IFF), 12.29% 138 (UK, Ifoods), 14.13% 139 (Germany, PIF), 15.00% 142 (Turkey, EPIF), 19.80% 143 (Turkey, IFF), 39.71% 141 (Austria, EPIF), 60.53% 144 (France, EPIF), and 100.00% 145 (Turkey, raw PIF); 4.46% 146 (USA, EPIF) and 62.00% 147 (Mexico, PIF) in North America, and 0.00% 148 (Brazil, EPIF), 4.69% 149 (Chile), 17.91% 148 (Brazil, PIF), 23.33% 150 (Brazil, CPIF), 34.31% 151 (Colombia, IFF), 44.44% 152 (Brazil, CPIF), and 66.67% 150 (Brazil, IFF) from the South America.…”